BLOOD CANCER November 18, 2024 by Marisa Wexler, MS Aucatzyl, a cell therapy, approved in US for adults with advanced B-ALL The U.S. Food and Drug Administration (FDA) has approved the cell therapy Aucatzyl (obecabtagene…